{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T09:18:10Z","timestamp":1788081490887,"version":"build-2784847793"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270171"],"award-info":[{"award-number":["82270171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["71003Y3035"],"award-info":[{"award-number":["71003Y3035"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.canlet.2024.216730","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T12:12:15Z","timestamp":1707826335000},"page":"216730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["STAT5 is essential for inducing the suppressive subset and attenuate cytotoxicity of V\u03b42+ T cells in acute myeloid leukemia"],"prefix":"10.1016","volume":"587","author":[{"given":"Cong","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keli","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7857-7147","authenticated-orcid":false,"given":"Xinyu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.216730_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","article-title":"Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment","volume":"122","author":"Mussai","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.216730_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215691","article-title":"Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies","volume":"538","author":"Ye","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216730_bib3","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41590-018-0253-5","article-title":"The gammadeltaTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness","volume":"19","author":"Melandri","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","article-title":"Gammadelta T cells: pleiotropic immune effectors with therapeutic potential in cancer","volume":"19","author":"Silva-Santos","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2024.216730_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41423-020-0504-x","article-title":"Cancer immunotherapy with gammadelta T cells: many paths ahead of us","volume":"17","author":"Kabelitz","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fimmu.2014.00575","article-title":"Gammadelta T lymphocytes as a first line of immune Defense: old and new ways of antigen recognition and implications for cancer immunotherapy","volume":"5","author":"Poggi","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/CJI.0b013e318207ecfb","article-title":"Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded gammadeltaTcells: a phase I clinical study","volume":"34","author":"Sakamoto","year":"2011","journal-title":"J. Immunother."},{"key":"10.1016\/j.canlet.2024.216730_bib8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fimmu.2018.00800","article-title":"Improving the efficiency of Vgamma9Vdelta2 T-cell immunotherapy in cancer","volume":"9","author":"Hoeres","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/CJI.0b013e318245bb1e","article-title":"Tumor-promoting versus tumor-antagonizing roles of gammadelta T cells in cancer immunotherapy: results from a prospective phase I\/II trial","volume":"35","author":"Kunzmann","year":"2012","journal-title":"J. Immunother."},{"key":"10.1016\/j.canlet.2024.216730_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1009709","article-title":"Identification of the immunosuppressive effect of gammadelta T cells correlated to bone morphogenetic protein 2 in acute myeloid leukemia","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri.2015.18","article-title":"Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease","volume":"16","author":"DuPage","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib12","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1038\/s41467-019-12464-3","article-title":"Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease","volume":"10","author":"Szabo","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216730_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2024.216730_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004566","article-title":"Expression of RORgammat marks a pathogenic regulatory T cell subset in human colon cancer","volume":"4","author":"Blatner","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2024.216730_bib15","first-page":"11","article-title":"JAK-STAT signaling: a double-edged sword of immune regulation and cancer progression","author":"Owen","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.216730_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1359-6101(99)00011-8","article-title":"Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation","volume":"10","author":"Grimley","year":"1999","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.canlet.2024.216730_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mce.2017.04.025","article-title":"Crosstalk between STAT5 activation and PI3K\/AKT functions in normal and transformed mammary epithelial cells","volume":"451","author":"Radler","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.canlet.2024.216730_bib18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1182\/blood-2017-04-777128","article-title":"mTOR masters monocyte development in bone marrow by decreasing the inhibition of STAT5 on IRF8","volume":"131","author":"Zhao","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.216730_bib19","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.4049\/jimmunol.173.6.3962","article-title":"Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation","volume":"173","author":"Arnaud","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1101\/gad.1643908","article-title":"Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B","volume":"22","author":"Hennighausen","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2024.216730_bib21","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jaci.2021.07.041","article-title":"TLR3-driven IFN-beta antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung","volume":"149","author":"Tei","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1084\/jem.20111174","article-title":"STAT5 is a potent negative regulator of TFH cell differentiation","volume":"209","author":"Johnston","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2024.216730_bib23","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41467-019-08960-1","article-title":"Essential and non-overlapping IL-2Ralpha-dependent processes for thymic development and peripheral homeostasis of regulatory T cells","volume":"10","author":"Toomer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216730_bib24","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1002\/j.1460-2075.1994.tb06756.x","article-title":"Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription","volume":"13","author":"Gouilleux","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2024.216730_bib25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216043","article-title":"CD8(+) T cell exhaustion and cancer immunotherapy","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216730_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215888","article-title":"The tumor microenvironment's role in malignant progression and treatment response","volume":"548","author":"Frankiw","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216730_bib28","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1158\/0008-5472.CAN-14-3228","article-title":"The emerging Protumor role of gammadelta T lymphocytes: implications for cancer immunotherapy","volume":"75","author":"Rei","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216730_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","article-title":"Gammadelta T cells: origin and fate, subsets, diseases and immunotherapy","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2024.216730_bib30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nri2654","article-title":"The functional plasticity of T cell subsets","volume":"9","author":"Bluestone","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215925","article-title":"TGF-beta signaling networks in the tumor microenvironment","volume":"550","author":"Chan","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216730_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ni.2785","article-title":"NF-kappaB control of T cell development","volume":"15","author":"Gerondakis","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nri2958","article-title":"Genomic views of STAT function in CD4+ T helper cell differentiation","volume":"11","author":"O'Shea","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-7613(03)00292-9","article-title":"Stat5 activation plays a critical role in Th2 differentiation","volume":"19","author":"Zhu","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.216730_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0609.2004.00242.x","article-title":"The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells","volume":"72","author":"Baskiewicz-Masiuk","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.canlet.2024.216730_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/emmm.201000062","article-title":"Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia","volume":"2","author":"Hoelbl","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.canlet.2024.216730_bib38","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood-2009-06-227603","article-title":"Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal","volume":"114","author":"Heuser","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.216730_bib39","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41375-017-0005-9","article-title":"Pharmacologic inhibition of STAT5 in acute myeloid leukemia","volume":"32","author":"Wingelhofer","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2024.216730_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2008.08.014","article-title":"Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates","volume":"14","author":"Kotecha","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2024.216730_bib41","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib42","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/ni1207-1285","article-title":"Competition for cytokines: T(reg) cells take all","volume":"8","author":"Scheffold","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7729","article-title":"Oncogenic JAK2(V617F) causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms","volume":"10","author":"Prestipino","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2024.216730_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2021.09.022","article-title":"Plasmacytoid dendritic cells recruited by HIF-1alpha\/eADO\/ADORA1 signaling induce immunosuppression in hepatocellular carcinoma","volume":"522","author":"Pang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216730_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41568-022-00537-3","article-title":"STAT proteins in cancer: orchestration of metabolism","volume":"23","author":"Li","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2024.216730_bib46","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1172\/JCI0215337","article-title":"Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia","volume":"110","author":"Synnestvedt","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.216730_bib47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1158\/2326-6066.CIR-22-0398","article-title":"IL18 receptor signaling regulates tumor-reactive CD8+ T-cell exhaustion via activation of the IL2\/STAT5\/mTOR pathway in a pancreatic cancer model","volume":"11","author":"Lutz","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2024.216730_bib48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","article-title":"IL-2 regulates tumor-reactive CD8(+) T cell exhaustion by activating the aryl hydrocarbon receptor","volume":"22","author":"Liu","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2024.216730_bib49","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/leu.2014.84","article-title":"TGF-beta upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma","volume":"28","author":"Yang","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2024.216730_bib50","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41375-017-0005-9","article-title":"Pharmacologic inhibition of STAT5 in acute myeloid leukemia","volume":"32","author":"Wingelhofer","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2024.216730_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200553","article-title":"Stafiba: a STAT5-selective small-molecule inhibitor","volume":"24","author":"Eckhardt","year":"2023","journal-title":"Chembiochem"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352400123X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352400123X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:13:36Z","timestamp":1759594416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352400123X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":51,"alternative-id":["S030438352400123X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216730","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT5 is essential for inducing the suppressive subset and attenuate cytotoxicity of V\u03b42+ T cells in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216730"}}